Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.


Effective oral medication for use in men with Peyronie's disease (Peyronies Disease) has been an area of interest of the medical community and lay public for decades. Isolated septal scars (ISS) without evidence of penile deformity is a relatively new clinical entity, and at present, there is paucity in the published literature regarding its treatment. Current research into the use of phosphodiesterase type 5 (PDE5) inhibitors in regulating penile erectile response has revealed an alternative role for PDE5 inhibitors in decreasing oxidative stress-associated inflammatory change as seen in Peyronies Disease.

I didn't find the right solution from the Internet.

[Non - Relevant links removed]